Personal Health Libraries for Formerly Incarcerated Individuals
Launched by YALE UNIVERSITY · Jun 28, 2022
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new tool called Personal Health Libraries (PerHL) to see how well it works for people who have recently been released from prison. The goal is to help these individuals manage their health information better, especially if they have chronic conditions like diabetes or high blood pressure. The trial is still in the planning stages and has not started recruiting participants yet.
To be eligible for this study, participants need to be at least 18 years old, speak English, and have at least one ongoing health issue. They also need to have been released from a correctional facility within the past year and currently engage in primary care, which means they see a doctor for regular health check-ups. Unfortunately, those with visual or cognitive impairments, language barriers, or plans to move away will not be able to participate. If you join the study, you can expect to learn more about managing your health and may help researchers understand how to improve health resources for people in similar situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • English-speaking
- • have at least one chronic condition
- • engaged in primary care in the community
- • have been released from a correctional facility in the past year.
- Exclusion Criteria:
- • visual impairments
- • cognitive impairments
- • language barriers
- • planned relocation
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Patients applied
Trial Officials
Karen Wang, MD, MHS
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials